Loading stock data…
Tactile Systems Technology (TCMD)
$21.73-0.14 (-0.64%)
Market ClosedLast close Sep 8
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Tactile Systems Technology, Inc. in the Healthcare sector is trading at $21.73 with a market capitalization of $595M. Wall Street consensus targets $39.00 (3 analysts), implying a +79.5% move over the next 12 months. The stock is currently 42% below its 52-week high of $37.77, remaining 19.2% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. Risk note: RSI 19 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +79.5% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 19) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $75.27M↓ | $103.59M↑ | $85.75M↑ | $78.91M↑ | $61.27M |
| Gross Profit | $57.61M↓ | $81.01M↑ | $65.00M↑ | $58.79M↑ | $45.35M |
| Operating Income | -$1.53M↓ | $18.77M↑ | $10.96M↑ | $4.08M↑ | -$4.54M |
| Net Income | -$1.76M↓ | $10.63M↑ | $8.21M↑ | $3.22M↑ | -$2.97M |
Peer Comparison
JNJUNHPFE
Fundamentals
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of ly...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$595.15M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
9.32%
Volume
Today's trading volume
233,362
Recent News
Anteris Technologies appoints Brent Moen as chief financial officer
Anteris Technologies Pty Ltd (ASX:AVR, NASDAQ:AVR) has appointed experienced financial executive Brent Moen as chief financial officer, effective September 12, 2026 AEST. Moen brings more than 25 years of leadership experience across public and private companies, with expertise spanning...
Tactile Systems Technology (TCMD) Q2 2026 Earnings Call Transcript
Revenue grew 9% as lymphedema strength offset airway clearance inventory headwinds.
Tactile Systems Technology, Inc. Q2 2026 Earnings Call Summary
Moby summary of Tactile Systems Technology, Inc.'s Q2 2026 earnings call
Tactile Systems Technology Q2 Earnings Call Highlights
Tactile Systems Technology (NASDAQ:TCMD), doing business as Tactile Medical, reported second-quarter revenue growth and higher profitability, led by its lymphedema business, while updating its full-year outlook to reflect temporary inventory effects in its airway-clearance segment. Total revenue ro
Tactile Systems Technology (TCMD) Beats Q2 Earnings and Revenue Estimates
Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of +142.86% and +0.19%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?